2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Late Breaking I

96.32 - Pre-transplant maternal-fetal immune status predicts allograft outcome

Presenter: William, Burlingham, Madison, United States
Authors: Dutta P., Dart M., David A., Schumacher S., Burlingham W.

PRE-TRANSPLANT MATERNAL-FETAL IMMUNE STATUS PREDICTS ALLOGRAFT OUTCOME

LATE BREAKING I

P. Dutta1, M. Dart2, A. David3, S.M. Schumacher1, W.J. Burlingham4
1Surgery, University of Wisconsin-Madison, Madison/UNITED STATES OF AMERICA, 2Surgery - Division Of Transplantation, University of Wisconsin, Madison/UNITED STATES OF AMERICA, 3Surgery, University of Wisconsin-Madison, Madison/WI/UNITED STATES OF AMERICA, 4Surgery, University of Wisconsin, Madison/WI/UNITED STATES OF AMERICA

Body: Introduction: Exposure to non-inherited maternal antigens (NIMA) in fetal and neonatal life of an F1 backcross (BDF1female x B6 male) mouse can result in lifelong tolerance to allografts expressing the NIMA (H2d) in some (50%), but not all offspring. We discovered previously that NIMA-specificregulatory CD4 T cells were directly correlated with level of maternal microchimerism (MMc), indicating a causative link between the two. Whether high levels of Tregs and MMc could be used to predictsuccessful graft outcome is unknown. Hypothesis: Pretransplant levels of NIMA-specific regulatory T cells will predict subsequent NIMA-specific tolerance to allografts. Methods: Six-week old F1 backcross males were bled and H2bxd heterozygous vs. H2bxb homozygous offspring were determined by flow cytometry typing of PBMC.H2bxb homozygotes were immunized with tetanus toxoid (TT). Two weeks later, hemisplenectomy was performed to obtain splenocytes from NIMAd-exposed mice. Indirect delayed typehypersensitivity (DTH) assays were performed by transfer of splenocytes into a naïve B6 mouse footpad to measure bystander suppression of recall TT response in presence of maternal (BDF1)antigens, a measurement of NIMA-specific regulatory T cells. After a week, DBA/2 hearts expressing NIMA (H2d) were transplanted in the abdominal cavity of the offspring. Results: Splenocytes from 15 NIMAd-exposed offspring were tested. Ten were negative for suppression, while 5 suppressed recall TT response in presence of maternal antigens to avarying degree (20-55%) indicating the presence of NIMA-specific T regulatory cells. Out of the latter 5 offspring, 4 have beating DBA/2 hearts (f/u d 71, d18, d 12, d12 post transplant) as of thetime of writing and only one has rejected the heart (d.11). In contrast, all 10 of the NIMAd-exposed “non-regulator”offspring rejected DBA/2 hearts by day 9-11 post transplant.BDF1 skin graft prolongation was also only observed in pre-transplant regulators, not in non-regulators. Conclusion: While f/u time is still short, the finding of a predictivecorrelation between DTH suppression of TT recall response in presence of maternal antigens and NIMA-specific tolerance suggests that one may predict NIMA-specific tolerance before transplantation. Iftranslated to human solid organ transplantation, this will allow us to prescreen recipients of a living related donor kidney allograft for enrollment in tolerance trials.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada